AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 151 filers reported holding AGIOS PHARMACEUTICALS INC in Q1 2015. The put-call ratio across all filers is 1.66 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $21,904,000 | +36.6% | 375,084 | -2.4% | 0.02% | +38.5% |
| Q4 2016 | $16,038,000 | -10.4% | 384,264 | +13.4% | 0.01% | -13.3% |
| Q3 2016 | $17,893,000 | +361.4% | 338,755 | +254.7% | 0.02% | +400.0% |
| Q1 2016 | $3,878,000 | -38.9% | 95,501 | -2.4% | 0.00% | -40.0% |
| Q4 2015 | $6,349,000 | -52.8% | 97,803 | -48.7% | 0.01% | -16.7% |
| Q3 2015 | $13,446,000 | -59.8% | 190,486 | -36.7% | 0.01% | -77.8% |
| Q2 2015 | $33,428,000 | +22.2% | 300,770 | +3.6% | 0.03% | +17.4% |
| Q1 2015 | $27,366,000 | +85.7% | 290,205 | +120.7% | 0.02% | +76.9% |
| Q4 2014 | $14,736,000 | – | 131,520 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Eagle Health Investments LP | 431,413 | $12,558,000 | 3.09% |
| Casdin Capital, LLC | 2,090,000 | $60,840,000 | 2.73% |
| Rock Springs Capital Management LP | 2,665,275 | $77,586,000 | 1.95% |
| Bellevue Group AG | 4,129,292 | $120,204,000 | 1.40% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 1,177,374 | $34,273,000 | 1.05% |
| Altium Capital Management LP | 66,196 | $1,927,000 | 0.64% |
| ArrowMark Colorado Holdings LLC | 1,295,948 | $37,725,000 | 0.33% |
| FARALLON CAPITAL MANAGEMENT LLC | 1,333,012 | $38,804,000 | 0.19% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 21,500 | $707,000 | 0.16% |
| Virtus ETF Advisers LLC | 11,541 | $336,000 | 0.15% |